# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sana Biotech stock soars after outspoken stock promoter Eric Jackson names it as his latest potential "100-bagger."
Wedbush analyst Martin Fan initiates coverage on Sana Biotechnology (NASDAQ:SANA) with a Outperform rating and announces Pr...
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(...